Two agents could take AML therapy in new directionsJune 7, 2018Leukemia, Myelodysplasia, TransplantationAML
Emicizumab granted priority review for hemophilia A without inhibitorsJune 7, 2018ThrombosisPharmacyBleeding Disorders
Single-agent acalabrutinib ‘impressive’ in patients with WMJune 6, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves first biosimilar pegfilgrastimJune 5, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Over 1100 new meds, vaccines being developed to treat cancerJune 4, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
VF incidence increases significantly in kids after ALL treatmentMay 31, 2018Leukemia, Myelodysplasia, TransplantationPediatricsALL
FDA grants priority review to gilteritinib for R/R AMLMay 30, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
